Literature DB >> 28723418

Beta3 adrenergic receptor stimulation in human macrophages inhibits NADPHoxidase activity and induces catalase expression via PPARγ activation.

Tarik Hadi1, Romain Douhard2, Alexandre M M Dias2, Maeva Wendremaire3, Maria Pezzè2, Marc Bardou4, Paul Sagot5, Carmen Garrido6, Frédéric Lirussi7.   

Abstract

The beta3 adrenergic receptor (β3-AR) stimulation plays a protective role against preterm labor by blocking myometrial contraction, cytokine production, remodeling and apoptosis. We previously demonstrated that macrophage-induced ROS production in the myometrium was a key element leading to the induction of all these labor-associated features. We thus aimed to investigate if the β3-AR could be expressed in human macrophages and could trigger its protective role in the myometrium by directly inhibiting ROS production. Using lipopolysaccharide (LPS)-stimulated myometrial samples and cell co-culture experiments, we demonstrated that β3-AR stimulation inhibits the activation of the NADPH oxidase, leading to the subsequent inhibition of ROS production by macrophages. This antioxidant effect was associated with a potent anti-inflammatory response in macrophages. Furthermore, we observed that β3-AR leads to the expression of catalase not only in macrophages but also in myometrial cells, thereby preventing the transactivation of myometrial cells by hydrogen peroxide. Pharmacological experiments allowed us to demonstrate that these effects were driven by an Erk1/2-mediated activation of the antioxidant transcription factor PPARγ. These results suggest that β3-AR protective effects in the myometrium could be due to its dual antioxidant properties. Further, the effects observed in a macrophage could highlight new applications in chronic inflammatory diseases.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Macrophage; PPARγ; Preterm labor; ROS; beta3 adrenergic receptor

Mesh:

Substances:

Year:  2017        PMID: 28723418     DOI: 10.1016/j.bbamcr.2017.07.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  14 in total

1.  β3 -Adrenoceptor as a potential immuno-suppressor agent in melanoma.

Authors:  Maura Calvani; Gennaro Bruno; Massimo Dal Monte; Romina Nassini; Filippo Fontani; Arianna Casini; Lorenzo Cavallini; Matteo Becatti; Francesca Bianchini; Francesco De Logu; Giulia Forni; Giancarlo la Marca; Lido Calorini; Paola Bagnoli; Paola Chiarugi; Alberto Pupi; Chiara Azzari; Pierangelo Geppetti; Claudio Favre; Luca Filippi
Journal:  Br J Pharmacol       Date:  2019-05-09       Impact factor: 8.739

2.  Selenium Deficiency Induces Apoptosis and Necroptosis Through ROS/MAPK Signal in Human Uterine Smooth Muscle Cells.

Authors:  Yueyang Wang; Xiaojing Li; Yujie Yao; Xia Zhao; Xu Shi; Yan Cai
Journal:  Biol Trace Elem Res       Date:  2021-09-04       Impact factor: 3.738

3.  β 3 Adrenergic Receptor Stimulation Promotes Reperfusion in Ischemic Limbs in a Murine Diabetic Model.

Authors:  Kristen J Bubb; Dhanya Ravindran; Siân P Cartland; Meghan Finemore; Zoe E Clayton; Michael Tsang; Owen Tang; Mary M Kavurma; Sanjay Patel; Gemma A Figtree
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

4.  β3-Adrenoreceptors Control Mitochondrial Dormancy in Melanoma and Embryonic Stem Cells.

Authors:  Maura Calvani; Lorenzo Cavallini; Annalisa Tondo; Valentina Spinelli; Luisa Ricci; Amada Pasha; Gennaro Bruno; Daniela Buonvicino; Elisabetta Bigagli; Marina Vignoli; Francesca Bianchini; Laura Sartiani; Maura Lodovici; Roberto Semeraro; Filippo Fontani; Francesco De Logu; Massimo Dal Monte; Paola Chiarugi; Claudio Favre; Luca Filippi
Journal:  Oxid Med Cell Longev       Date:  2018-11-13       Impact factor: 6.543

Review 5.  Everything You Always Wanted to Know about β3-AR * (* But Were Afraid to Ask).

Authors:  Giorgia Schena; Michael J Caplan
Journal:  Cells       Date:  2019-04-16       Impact factor: 6.600

Review 6.  Spotlight on ROS and β3-Adrenoreceptors Fighting in Cancer Cells.

Authors:  Maura Calvani; Angela Subbiani; Marina Vignoli; Claudio Favre
Journal:  Oxid Med Cell Longev       Date:  2019-12-14       Impact factor: 6.543

7.  Pyridinecarboxylic Acid Derivative Stimulates Pro-Angiogenic Mediators by PI3K/AKT/mTOR and Inhibits Reactive Nitrogen and Oxygen Species and NF-κB Activation Through a PPARγ-Dependent Pathway in T. cruzi-Infected Macrophages.

Authors:  Federico Nicolás Penas; Davide Carta; Ágata Carolina Cevey; María Jimena Rada; Azul Victoria Pieralisi; María Grazia Ferlin; María Elena Sales; Gerardo A Mirkin; Nora Beatriz Goren
Journal:  Front Immunol       Date:  2020-01-09       Impact factor: 7.561

8.  Lipoproteins LDL versus HDL as nanocarriers to target either cancer cells or macrophages.

Authors:  Tarik Hadi; Christophe Ramseyer; Thomas Gautier; Pierre-Simon Bellaye; Tatiana Lopez; Antonin Schmitt; Sarah Foley; Semen Yesylevskyy; Thibault Minervini; Romain Douhard; Lucile Dondaine; Lil Proukhnitzky; Samir Messaoudi; Maeva Wendremaire; Mathieu Moreau; Fabrice Neiers; Bertrand Collin; Franck Denat; Laurent Lagrost; Carmen Garrido; Frederic Lirussi
Journal:  JCI Insight       Date:  2020-12-17

9.  β3-Adrenoreceptor Activity Limits Apigenin Efficacy in Ewing Sarcoma Cells: A Dual Approach to Prevent Cell Survival.

Authors:  Amada Pasha; Marina Vignoli; Angela Subbiani; Alessio Nocentini; Silvia Selleri; Paola Gratteri; Annalisa Dabraio; Tommaso Casini; Luca Filippi; Ilaria Fotzi; Claudio Favre; Maura Calvani
Journal:  Int J Mol Sci       Date:  2019-04-30       Impact factor: 5.923

Review 10.  Highlighting the Potential for Chronic Stress to Minimize Therapeutic Responses to Radiotherapy through Increased Immunosuppression and Radiation Resistance.

Authors:  Minhui Chen; Anurag K Singh; Elizabeth A Repasky
Journal:  Cancers (Basel)       Date:  2020-12-20       Impact factor: 6.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.